Eisai Co., Ltd. and Biogen Inc have announced that the humanised amyloid-beta (Aβ) monoclonal antibody Leqembi (Lecanemab) has been granted a Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain. Lecanemab...
Read More
2 Minutes
